Yanxia Lu

1.6k total citations
28 papers, 1.3k citations indexed

About

Yanxia Lu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yanxia Lu has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Yanxia Lu's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (6 papers). Yanxia Lu is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (6 papers). Yanxia Lu collaborates with scholars based in China and Croatia. Yanxia Lu's co-authors include Xuenong Li, Lin Zheng, Jianming Zhang, Xiaomin Li, Chang Zhou, Yuhan Hu, Chun Lin, Min Hong, Wenjuan Zhang and Zheying Zhang and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Yanxia Lu

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanxia Lu China 19 1.0k 843 194 110 109 28 1.3k
Chengfei Jiang China 21 880 0.8× 707 0.8× 168 0.9× 87 0.8× 97 0.9× 46 1.2k
Nobuhiko Sugito Japan 22 958 0.9× 771 0.9× 109 0.6× 113 1.0× 103 0.9× 36 1.2k
Zerong Cai China 10 1.0k 1.0× 750 0.9× 125 0.6× 71 0.6× 77 0.7× 25 1.2k
Yingke Liang China 13 763 0.7× 551 0.7× 253 1.3× 124 1.1× 158 1.4× 29 1.1k
Yanni Ma China 24 1.3k 1.3× 1.1k 1.3× 136 0.7× 137 1.2× 63 0.6× 52 1.6k
Geyan Wu China 21 849 0.8× 568 0.7× 179 0.9× 135 1.2× 160 1.5× 29 1.1k
Yi Sang China 19 885 0.9× 433 0.5× 220 1.1× 98 0.9× 108 1.0× 44 1.1k
Huiwen Yan China 15 870 0.8× 553 0.7× 196 1.0× 140 1.3× 91 0.8× 24 1.2k
Enhua Wang China 16 651 0.6× 614 0.7× 154 0.8× 92 0.8× 73 0.7× 26 867

Countries citing papers authored by Yanxia Lu

Since Specialization
Citations

This map shows the geographic impact of Yanxia Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanxia Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanxia Lu more than expected).

Fields of papers citing papers by Yanxia Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanxia Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanxia Lu. The network helps show where Yanxia Lu may publish in the future.

Co-authorship network of co-authors of Yanxia Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanxia Lu. A scholar is included among the top collaborators of Yanxia Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanxia Lu. Yanxia Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Peiling, Lei Liu, Yujia Chen, et al.. (2024). The lipid-metabolism enzyme ECI2 reduces neutrophil extracellular traps formation for colorectal cancer suppression. Nature Communications. 15(1). 7184–7184. 19 indexed citations
2.
Lu, Yanxia, et al.. (2024). Multifunctional Hydrogel Strategies for Myocardial Infarction: From Tissue Repair to Cardiac Regeneration. Advanced Therapeutics. 8(1). 1 indexed citations
3.
4.
Li, Xiaomin, Jianjun Wang, Weihao Lin, et al.. (2022). circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop. Molecular Cancer. 21(1). 135–135. 24 indexed citations
5.
Zhang, Wei, Xiaomin Li, Wenjuan Zhang, et al.. (2021). The LncRNA CASC11 Promotes Colorectal Cancer Cell Proliferation and Migration by Adsorbing miR-646 and miR-381-3p to Upregulate Their Target RAB11FIP2. Frontiers in Oncology. 11. 657650–657650. 12 indexed citations
6.
Zhang, Wenjuan, Yanxia Lu, Xiaomin Li, et al.. (2019). IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation. Journal of Experimental & Clinical Cancer Research. 38(1). 296–296. 32 indexed citations
7.
Zhang, Wei, Yanxia Lu, Xiaomin Li, et al.. (2018). CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer. Biochemical and Biophysical Research Communications. 500(2). 196–203. 46 indexed citations
8.
Li, Xiaomin, Jianjun Wang, Chao Zhang, et al.. (2018). Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. The Journal of Pathology. 246(2). 166–179. 211 indexed citations
9.
Lin, Chun, Jianming Zhang, Yanxia Lu, et al.. (2018). NIT1 suppresses tumour proliferation by activating the TGFβ1–Smad2/3 signalling pathway in colorectal cancer. Cell Death and Disease. 9(3). 263–263. 22 indexed citations
10.
Zhang, Fan, Yanxia Lu, Qing Chen, et al.. (2017). Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis. Cellular Signalling. 36. 67–78. 31 indexed citations
11.
Zhang, Zheying, Jianming Zhang, Yanxia Lu, et al.. (2017). HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway. PLoS ONE. 12(7). e0179741–e0179741. 68 indexed citations
12.
Zhang, Zheying, Chang Zhou, Zuoyang Zhang, et al.. (2016). Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Letters. 376(1). 62–73. 200 indexed citations
13.
Lu, Yanxia, Hui Yang, Yuan Li, et al.. (2015). Overexpression of miR-335 confers cell proliferation and tumour growth to colorectal carcinoma cells. Molecular and Cellular Biochemistry. 412(1-2). 235–245. 32 indexed citations
14.
Zheng, Lin, Yu‐Qin Zhang, Yan Liu, et al.. (2015). MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer. Journal of Translational Medicine. 13(1). 252–252. 140 indexed citations
15.
Li, Yuan, Chang Zhou, Yanxia Lu, et al.. (2015). IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1. Cancer Letters. 359(1). 136–147. 59 indexed citations
16.
Lu, Yanxia, Yuan Li, Xiaolei Xue, et al.. (2014). Regulation of Colorectal Carcinoma Stemness, Growth, and Metastasis by an miR-200c -Sox2–Negative Feedback Loop Mechanism. Clinical Cancer Research. 20(10). 2631–2642. 83 indexed citations
17.
Zhang, Chao, Chang Zhou, Xiaojin Wu, et al.. (2014). Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells. Carcinogenesis. 35(12). 2771–2777. 20 indexed citations
18.
Zhou, Chang, Lijing Wang, Yanxia Lu, et al.. (2013). MiR-339-5p Regulates the Growth, Colony Formation and Metastasis of Colorectal Cancer Cells by Targeting PRL-1. PLoS ONE. 8(5). e63142–e63142. 67 indexed citations
19.
Zhang, Chao, Hong Liu, Yanxia Lu, et al.. (2012). A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro. Clinical & Experimental Metastasis. 29(3). 185–196. 46 indexed citations
20.
Huang, Wenli, J. Pan, Ming Xu, et al.. (2008). Changes and effects of plasma arginine vasopressin in traumatic brain injury. Journal of Endocrinological Investigation. 31(11). 996–1000. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengfei Jiang Breakdown of academic impact, for papers by Nobuhiko Sugito Breakdown of academic impact, for papers by Zerong Cai Breakdown of academic impact, for papers by Yingke Liang Breakdown of academic impact, for papers by Yanni Ma Breakdown of academic impact, for papers by Geyan Wu Breakdown of academic impact, for papers by Yi Sang Breakdown of academic impact, for papers by Huiwen Yan Breakdown of academic impact, for papers by Enhua Wang
Rankless by CCL
2026